# Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass

> **NCT03782350** · PHASE4 · COMPLETED · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 3079 (actual)

## Conditions studied

- Homeostasis
- Cardiac Surgery

## Interventions

- **DRUG:** Tranexamic Acid Dosage 1
- **DRUG:** Tranexamic Acid Dosage 2

## Key facts

- **NCT ID:** NCT03782350
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-26
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-11-27
- **Target enrollment:** 3079 (ACTUAL)
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03782350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03782350, "Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT03782350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*